4,840
Views
45
CrossRef citations to date
0
Altmetric
Review

Polymers, responsiveness and cancer therapy

&
Pages 395-405 | Received 27 Sep 2018, Accepted 24 Nov 2018, Published online: 27 Jan 2019

References

  • Salas-Vega S, Iliopoulos O, Mossialos E. Assessment of overall survival, quality of life, and safety benefits associated with new cancer medicines. JAMA Oncol. 2017;3:382–390.
  • Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70.
  • Da Silva CG, Rueda F, Löwik CW. Combinatorial prospects of nano-targeted chemoimmunotherapy. Biomaterials. 2016;83:308–320.
  • Liu D, Auguste DT. Cancer targeted therapeutics: from molecules to drug delivery vehicles. J Control Release. 2015;219:632–643.
  • Hussain T, Nguyen QT. Molecular imaging for cancer diagnosis and surgery. Adv Drug Deliv Rev. 2014;66:90–100.
  • Duncan R, Vicent MJ, Greco F, et al. Polymer–drug conjugates: towards a novel approach for the treatment of endocrine-related cancer. Endocr Relat Cancer. 2005;12:S189–S199.
  • Safra T, Muggia F, Jeffers S, et al. Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2. Ann Oncol. 2000;11:1029–1033.
  • Soni G, Yadav KS. Communication of drug loaded nanogels with cancer cell receptors for targeted delivery. In: Suzuki J, Nakano T, Moore MJ, editors. Modeling, methodologies and tools for molecular and nano-scale communications. Cham: Springer; 2017. p.503–515.
  • Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science. 1998;279:377–380.
  • Cerchia L, de Franciscis V. Targeting cancer cells with nucleic acid aptamers. Trends Biotechnol. 2010;28:517–525.
  • Tayo LL. Stimuli-responsive nanocarriers for intracellular delivery. Biophys Rev. 2017;9:931–940.
  • Yang D-P, Oo MNNL, Deen GR, et al. Nano-star-shaped polymers for drug delivery applications. Macromol Rapid Commun 2017;38:1700410.
  • Singh B, Khurana RK, Garg B, et al. Stimuli-responsive systems with diverse drug delivery and biomedical applications: recent updates and mechanistic pathways. Crit Rev Ther Drug Carrier Syst. 2017;34:209–255.
  • Liu X, Yang Y, Urban MW. Stimuli-responsive polymeric nanoparticles. Macromol Rapid Commun. 2017;38:e1700030.
  • van Elk M, Murphy BP, Eufrásio-da-Silva T, et al. Nanomedicines for advanced cancer treatments: transitioning towards responsive systems. Int. J. Pharm. 2016;515:132–164.
  • Zhuang J, Gordon M, Ventura J, et al. Multi-stimuli responsive macromolecules and their assemblies. Chem Soc Rev. 2013;42:7421–7435.
  • Su Z, Jiang X. Multi-stimuli responsive amine-containing polyethers: novel building blocks for smart assemblies. Polymer 2016;93:221–239.
  • Shaikh RP, Pillay V, Choonara YE, et al. A review of multi-responsive membranous systems for rate-modulated drug delivery. AAPS PharmSciTech. 2010;11:441–459.
  • Stuart MA, Huck WT, Genzer J, et al. Emerging applications of stimuli-responsive polymer materials. Nature Mater. 2010;9:101–113.
  • Dissemond J, Witthoff M, Brauns TC, et al. PH-Wert des milieus chronischer wunden. Der Hautarzt. 2003;54:959–965.
  • de Las Heras Alarcon C, Pennadam S, Alexander C. Stimuli responsive polymers for biomedical applications. Chem Soc Rev. 2005;34:276–285.
  • Soni G, Yadav KS. High encapsulation efficiency of poloxamer-based injectable thermoresponsive hydrogels of etoposide. Pharm Dev Technol. 2014;19:651–661.
  • Soni G, Yadav KS. Nanogels as potential nanomedicine carrier for treatment of cancer: a mini review of the state of the art. Saudi Pharm J. 2016;24:133–139.
  • Loh XJ, del Barrio J, Toh PPC, et al. Triply triggered doxorubicin release from supramolecular nanocontainers. Biomacromolecules. 2012;13:84–91.
  • Wang K, Guo DS, Wang X, et al. Multistimuli responsive supramolecular vesicles based on the recognition of p-sulfonatocalixarene and its controllable release of doxorubicin. Acs Nano. 2011;5:2880–2894.
  • Klaikherd A, Nagamani C, Thayumanavan S. Multi-stimuli sensitive amphiphilic block copolymer assemblies. J Am Chem Soc. 2009;131:4830–4838.
  • Qiao ZY, Zhang R, Du FS, et al. Multi-responsive nanogels containing motifs of ortho ester, oligo (ethylene glycol) and disulfide linkage as carriers of hydrophobic anti-cancer drugs. J. Control. Release. 2011;152:57–66.
  • Chilkoti A, Dreher MR, Meyer DE. Design of thermally responsive, recombinant polypeptide carriers for targeted drug delivery. Adv Drug Deliv Rev. 2002;54:1093–1111.
  • Haider M, Megeed Z, Ghandehari H. Genetically engineered polymers: status and prospects for controlled release. J Control Release. 2004;95:1–26.
  • Hussain M, Shchepinov MS, Sohail M, et al. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides. J Control Release. 2004;99:139–155.
  • Nakamae K, Nizuka T, Miyata T, et al. Lysozyme loading and release from hydrogels carrying pendant phosphate groups. J Biomater Sci Polym Ed. 1998;9:43–53.
  • Dong J, Wang Y, Zhang J, et al. Multiple stimuli-responsive polymeric micelles for controlled release. Soft Matter. 2013;9:370–373.
  • Yadav KS, Saxena R, Soni G. Nanogels as targeted drug delivery vehicles. In: Vashist A, Kaushik AK, Ahmad S, Nair M, editors. Nanogels for Biomedical Applications. Vol. 30. Royal Society of Chemistry; 2017. p.143.
  • Putnam D, Zelikin AN, Izumrudov VA, et al. Polyhistidine-PEG:DNA nanocomposites for gene delivery. Biomaterials. 2003;24:4425–4433.
  • Isaacson KJ, Jensen MM, Subrahmanyam NB, et al. Matrix-metalloproteinases as targets for controlled delivery in cancer: an analysis of upregulation and expression. J Control Release. 2017;259:62–75.
  • Terada T, Iwai M, Kawakami S, et al. Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting. J Control Release. 2006;111:333–342.
  • Zhang X, Wang X, Zhong W, et al. Matrix metalloproteinases-2/9-sensitive peptide-conjugated polymer micelles for site-specific release of drugs and enhancing tumor accumulation: preparation and in vitro and in vivo evaluation. Int J Nanomedicine. 2016;11:1643.
  • Shargh VH, Hondermarck H, Liang M. Gelatin-albumin hybrid nanoparticles as matrix metalloproteinases-degradable delivery systems for breast cancer therapy. Nanomedicine (Lond). 2017;12:977–989.
  • Lee SJ, Jeong YI, Park HK, et al. Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery. Int J Nanomedicine. 2015;10:5489.
  • Han H, Valdepérez D, Jin Q, et al. Dual enzymatic reaction-assisted gemcitabine delivery systems for programmed pancreatic cancer therapy. Acs Nano. 2017;11:1281–1291.
  • Zhang C, Liu LH, Qiu WX, et al. A transformable chimeric peptide for cell encapsulation to overcome multidrug resistance. Small. 2018;14:1703321.
  • Zhang M, Xu C, Wen L, et al. A hyaluronidase responsive nanoparticle-based drug delivery system for targeting colon cancer cells. Cancer Res. 2016;76(24):7208–7218.
  • Jiang H, Shi X, Yu X, et al. Hyaluronidase enzyme-responsive targeted nanoparticles for effective delivery of 5-fluorouracil in colon cancer. Pharm Res. 2018;35:73.
  • Dong X, Yin W, Zhang X, et al. Intelligent MoS2 nanotheranostic for targeted and enzyme-/pH-/NIR-responsive drug delivery to overcome cancer chemotherapy resistance guided by PET imaging. ACS Appl Mater Interfaces. 2018;10:4271–4284.
  • Sharma R, Rawal RK, Gaba T, et al. Design, synthesis and ex vivo evaluation of colon-specific azo based prodrugs of anticancer agents. Bioorganic Med Chem Lett. 2013;23:5332–5338.
  • Rao J, Khan A. Enzyme sensitive synthetic polymer micelles based on the azobenzene motif. J Am Chem Soc. 2013;135:14056–14059.
  • Zhou Y, Maiti M, Sharma A, et al. Azo-based small molecular hypoxia responsive theranostic for tumor-specific imaging and therapy. J Control Release. 2018;288:14–22.
  • Cai Z, Zhang D, Lin X, et al. Glutathione responsive micelles incorporated with semiconducting polymer dots and doxorubicin for cancer photothermal-chemotherapy. Nanotechnology. 2017;28(42):425102.
  • Tu Y, Peng F, White PB, et al. Redox‐sensitive stomatocyte nanomotors: destruction and drug release in the presence of glutathione. Angew Chem Int Ed. 2017;56:7620–7624.
  • Ko NR, Oh JK. Glutathione-triggered disassembly of dual disulfide located degradable nanocarriers of polylactide-based block copolymers for rapid drug release. Biomacromolecules. 2014;15:3180–3189.
  • Huang Y, Dong R, Zhu X, et al. Photo-responsive polymeric micelles. Soft Matter. 2014;10:6121–6138.
  • Li Y, Qian Y, Liu T, et al. Light-triggered concomitant enhancement of magnetic resonance imaging contrast performance and drug release rate of functionalized amphiphilic diblock copolymer micelles. Biomacromolecules. 2012;13:3877–3886.
  • Sharma A, Garg T, Aman A, et al. Nanogel-an advanced drug delivery tool: current and future. Artif Cells Nanomed Biotechnol. 2016;44:165–177.
  • Khatun Z, Nurunnabi M, Nafiujjaman M, et al. A hyaluronic acid nanogel for photo–chemo theranostics of lung cancer with simultaneous light-responsive controlled release of doxorubicin. Nanoscale. 2015;7:10680–10689.
  • Don TM, Lu KY, Lin LJ, et al. Temperature/pH/Enzyme triple-responsive cationic protein/PAA-b-PNIPAAm nanogels for controlled anticancer drug and photosensitizer delivery against multidrug resistant breast cancer cells. Mol Pharmaceutics. 2017;14:4648–4660.
  • Xu X, Wang X, Luo W, et al. Triple cell-responsive nanogels for delivery of drug into cancer cells. Colloids Surf B Biointerfaces. 2018;163:362–368.
  • Yang HY, Li Y, Lee DS. Multifunctional and stimuli‐responsive magnetic nanoparticle‐based delivery systems for biomedical applications. Advanced Therapeutics. 2018;1:1800011.
  • Oerlemans C, Bult W, Bos M, et al. Polymeric micelles in anticancer therapy: targeting, imaging and triggered release. Pharm Res. 2010;27:2569–2589.
  • Zhang CY, Yang YQ, Huang TX, et al. Self-assembled pH-responsive MPEG-b-(PLA-co-PAE) block copolymer micelles for anticancer drug delivery. Biomaterials. 2012;33:6273–6283.
  • Yang X, Grailer JJ, Pilla S, et al. Tumor-targeting, pH-responsive, and stable unimolecular micelles as drug nanocarriers for targeted cancer therapy. Bioconjugate Chem. 2010;21:496–504.
  • Jia T, Huang S, Yang C, et al. Unimolecular micelles of pH-responsive star-like copolymers for co-delivery of anticancer drugs and small-molecular photothermal agents: a new drug-carrier for combinational chemo/photothermal cancer therapy. J Mater Chem B. 2017;5:8514–8524.
  • Sun J, Liu Y, Chen Y, et al. Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy. J Control Release. 2017;258:43–55.
  • Zhang Y, Guo Z, Cao Z, et al. Endogenous albumin-mediated delivery of redox-responsive paclitaxel-loaded micelles for targeted cancer therapy. Biomaterials. 2018;183:243–257.
  • Zhang T, Huang S, Lin H, et al. Enzyme and pH-responsive nanovehicles for intracellular drug release and photodynamic therapy. New J Chem. 2017;41:2468–2478.
  • Wang F, Klaikherd A, Thayumanavan S. Temperature sensitivity trends and multi-stimuli sensitive behavior in amphiphilic oligomers. J Am Chem Soc. 2011;133:13496–13503.
  • Knipe JM, Strong LE, Peppas NA. Enzyme-and pH-responsive microencapsulated nanogels for oral delivery of siRNA to induce TNF-α knockdown in the intestine. Biomacromolecules. 2016;17:788–797.
  • Jaiswal MK, De M, Chou SS, et al. Thermoresponsive magnetic hydrogels as theranostic nanoconstructs. ACS Appl Mater Interfaces. 2014;6:6237–6247.
  • Sadighian S, Rostamizadeh K, Hosseini MJ, et al. Magnetic nanogels as dual triggered anticancer drug delivery: toxicity evaluation on isolated rat liver mitochondria. Toxicol lett. 2017;278:18–29.
  • Fan T, Li M, Wu X, et al. Preparation of thermoresponsive and pH-sensitivity polymer magnetic hydrogel nanospheres as anticancer drug carriers. Colloids Surf B Biointerfaces. 2011;88:593–600.
  • Yang H, Wang Q, Huang S, et al. Smart pH/redox dual-responsive nanogels for on-demand intracellular anticancer drug release. ACS Appl Mater Interfaces. 2016;8:7729–7738.
  • Zhang X, Achazi K, Haag R. Boronate Cross‐linked ATP‐and pH‐Responsive Nanogels for Intracellular Delivery of Anticancer Drugs. Adv Healthcare Mater. 2015;4:585–592.
  • Li R, Feng F, Wang Y, et al. Folic acid-conjugated pH/temperature/redox multi-stimuli responsive polymer microspheres for delivery of anti-cancer drug. J Colloid Interface Sci. 2014;429:34–44.